Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $21.25.

Several equities analysts have recently commented on the company. JPMorgan Chase & Co. boosted their price objective on Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Piper Sandler lifted their target price on Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, January 6th. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Finally, UBS Group lifted their price objective on shares of Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, October 31st.

Alignment Healthcare Stock Performance

ALHC opened at $20.92 on Friday. The company has a 50 day simple moving average of $18.87 and a two-hundred day simple moving average of $16.68. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market cap of $4.19 billion, a P/E ratio of -174.33, a PEG ratio of 6.11 and a beta of 1.16. Alignment Healthcare has a 1-year low of $11.63 and a 1-year high of $21.67.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The company had revenue of $993.70 million for the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. Alignment Healthcare’s revenue for the quarter was up 43.5% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.14) EPS. Equities analysts forecast that Alignment Healthcare will post -0.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO John E. Kao sold 605,648 shares of Alignment Healthcare stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total value of $11,349,843.52. Following the sale, the chief executive officer directly owned 2,234,294 shares of the company’s stock, valued at approximately $41,870,669.56. The trade was a 21.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Hyong Kim sold 16,506 shares of the business’s stock in a transaction dated Tuesday, January 6th. The stock was sold at an average price of $21.35, for a total value of $352,403.10. Following the completion of the sale, the insider owned 333,133 shares in the company, valued at $7,112,389.55. This represents a 4.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 1,918,532 shares of company stock worth $36,505,338. 6.60% of the stock is owned by corporate insiders.

Institutional Trading of Alignment Healthcare

A number of large investors have recently added to or reduced their stakes in ALHC. Strs Ohio bought a new position in Alignment Healthcare in the first quarter worth approximately $600,000. Inspire Investing LLC bought a new stake in Alignment Healthcare during the 3rd quarter valued at $1,129,000. Ameritas Investment Partners Inc. lifted its holdings in shares of Alignment Healthcare by 32.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after buying an additional 3,225 shares during the period. Schroder Investment Management Group lifted its holdings in shares of Alignment Healthcare by 28.7% in the 2nd quarter. Schroder Investment Management Group now owns 248,163 shares of the company’s stock worth $3,437,000 after buying an additional 55,314 shares during the period. Finally, Jump Financial LLC grew its position in shares of Alignment Healthcare by 173.8% during the 2nd quarter. Jump Financial LLC now owns 1,056,600 shares of the company’s stock worth $14,792,000 after buying an additional 670,750 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.